So far, the stock has hit a high of 181.05 and a low of 163.85. On the BSE, over 22.26 lakh shares of the company were traded in the counter so far.

The initial public offer (IPO) of Standard Glass Lining Technology was subscribed 183.18 times. The issue opened for bidding on 6 January 2025, and it closed on 8 January 2025. The price band of the IPO was fixed between Rs 133 and 140 per share.

The initial public offer comprised a fresh issue of equity shares of Rs 210 crore and an offer for sale (OFS) of up to 1,42,89,367 equity shares of Rs 10 face value each.

Of the OFS, sales from promoters and promoter groups are 1,32,25,367 equity shares, and the balance of 1064000 equity shares is from other selling shareholders.

Of the net proceeds from the fresh equity issue, Rs 10 crore will be used for capital expenditure, Rs 130 crore for repaying loans of the company and its subsidiary, S2 Engineering Industry, Rs 30 crore for capex investment in S2 Engineering Industry, Rs 20 crore for strategic investments or acquisitions, and the balance for general corporate purposes.

Total consolidated outstanding borrowings as of the end of September 2024 stood at Rs 198.335 crore.

Ahead of the IPO, Standard Glass Lining Technology on Friday, 3 January 2025, raised Rs 123.01 crore from anchor investors. The board allotted 87.86 lakh shares at Rs 140 each to 10 anchor investors.

Standard Glass Lining Technology is one of the top five specialised engineering equipment manufacturers for pharmaceutical and chemical sectors in India with in-house capabilities across the entire value chain.

The company’s portfolio comprises core equipment used in the manufacturing of pharmaceutical and chemical products, which can be categorized into: reaction systems; storage, separation, and drying systems (SSD systems); and plant engineering and services (including other ancillary parts).

The firm reported a consolidated net profit of Rs 34.26 crore and sales of Rs 307.20 crore for the six months ended on 30 September 2024.